YHC 1139
Alternative Names: YHC-1139Latest Information Update: 12 Jul 2022
At a glance
- Originator Yuhan
- Class Gastric antisecretories
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Gastrointestinal disorders
Most Recent Events
- 30 Jun 2022 Early research in Gastrointestinal disorders in South Korea (unspecified route) (Yuhan company pipeline, June 2022)